PET and SPECT in the management of lung cancer

Current Opinion in Pulmonary Medicine

Volumn 8, Issue 4, 2002, Pages 257-264

  Sarinas, Priscilla S A ^a   Chitkara, Rajinder K ^a  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; DEPREOTIDE TC 99M; FLUORODEOXYGLUCOSE; GALLIUM 67; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; THALLIUM 201; THALLIUM CHLORIDE TL 201; TRACER;

CANCER RECURRENCE; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; INTERMETHOD COMPARISON; LUNG CANCER; LUNG NODULE; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0036286635     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200207000-00003     Document Type: Review

References (28)

1. Positron emission tomography: Brain tumors and lung cancer
2. Designing a new Study: III. Diagnostic Tests
3. Planning the Measurements: Precision and Accuracy
4. FDG-PET in oncology: There's more to it than looking at pictures
5. Cancer statistics, 2002
6. Positron emission tomography scanning: Current and future applications
7. Nuclear medicine imaging of lung cancer
8. Mediastinal staging of non-small-cell lung cancer
9. Positron emission tomography instrumentation
10. Positron emission tomography imaging in oncology
11. FDG-PET as a 'metabolic biopsy' tool in thoracic lesions with indeterminate biopsy
12. The clinical value of 18F-FDG detection with a dual-head coincidence camera: A review
13. Tl-201 chloride and Tc-99m MIBI accumulation in lung adenocarcinoma in patients with and without distant metastases
14. Evaluation of radiotherapeutic response in non-small cell lung cancer patients by technetium-99m MIBT and thallium-201 chloride SPET
15. Monitoring the chemotherapeutic response in primary lung cancer using 99mTc-MIBI SPET
16. Potential uses of computed tomography-SPECT and computed tomography-coincidence fusion images of the chest
17. Positron emission tomography in lung cancer
18. Changing pattern of lung cancer and its imaging: (201)TI SPECT versus [(18)F]FDG PET
19. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: A meta-analysis
20. Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging
21. Preoperative staging of non-small-cell lung cancer with positron-emission tomography
22. Comparison of [(18)F]FDG PET and (201)TI SPECT in evaluation of pulmonary nodules
23. 18F]FDG-PET
24. Analytical decision model for the cost-effective management of solitary pulmonary nodules
25. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, 'Onko-PET III', 21 July and 19 September 2000
26. Positron emission tomography in pulmonary masses where tissue diagnosis is unhelpful or not possible
27. Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer?
28. PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma